Article Processing Charges (APC)

The Journal of Clinical & Surgical Oncology Research (JCSOR) stands as a leading international, open-access, peer-reviewed platform devoted to propelling innovations in clinical and surgical oncology through rigorous scientific inquiry and practical applications. As a cornerstone for oncologists, surgeons, researchers, and healthcare policymakers, JCSOR investigates clinical trials, surgical interventions, minimally invasive techniques, patient management strategies, adjuvant therapies, and the integration of technology in cancer care. By exploring disease staging, prognostic models, survivorship issues, and health equity in oncology, the journal advocates for patient-centered approaches that optimize outcomes and reduce disparities in cancer treatment. Our open-access format delivers free, instant access to all readers, building an international consortium of professionals and catalyzing transformative discoveries in oncology without access limitations. Each manuscript is evaluated through thorough peer review by esteemed editorial board specialists, guaranteeing precision, ethical standards, and real-world relevance in clinical and surgical oncology.

Our Article Processing Charge (APC) of $1,150 is crafted to sustain JCSOR's mission of advancing clinical and surgical oncology excellence. This charge encompasses vital services like in-depth peer assessment, expert proofreading and layout, and rapid online publication via cutting-edge digital tools. It also supports upgrades to infrastructure, software, and secure long-term archiving, ensuring your findings remain accessible for ongoing clinical practice, surgical training, and oncology advancements. Authors in JCSOR enjoy heightened visibility across oncology databases, boosted citation opportunities, and the potential to inform surgical protocols, clinical guidelines, and equitable cancer care policies. We encourage diverse submissions, including clinical studies, surgical case series, systematic reviews, technical reports, and opinion pieces, all vetted to uphold academic excellence and drive progress in oncology research.

To encourage broad participation in clinical and surgical oncology, JCSOR upholds a flexible Waiver Policy that accounts for financial disparities. Recognizing that research budgets differ widely, we extend significant waivers to qualified authors from financially constrained institutions or developing regions. These waivers, ranging from partial to full, are reviewed case-by-case to ensure inclusivity and foster worldwide collaboration. Applications should be sent to the journal ahead of manuscript submission for prompt evaluation. This approach highlights our dedication to openness, empowering skilled researchers to disseminate their work unimpeded by economic constraints.

In addition, our Withdrawal Policy promotes accountability and efficiency in the publishing workflow. Authors can retract their submission before plagiarism verification without any fee. If withdrawal follows plagiarism checks (within 24 hours) and basic formatting, a $195 charge applies. For manuscripts post-peer review and nearing publication, the fee escalates to $465. Published articles require a $555 withdrawal fee. These costs reflect the editorial and technical investments made and are in line with our open-access framework, with payments being non-refundable after receipt to cover review, production, and distribution expenses.

Contributing to JCSOR places you at the vanguard of clinical and surgical oncology, where your research can refine surgical methods, enhance patient recovery, tackle healthcare inequalities, and elevate global cancer outcomes. Featuring no upfront submission costs and easy payment avenues such as credit cards or institutional accounts, the process is straightforward. For questions or APC adjustments, email accounts@medscienspublishinggroup.com. Ignite progress in oncology-submit your manuscript now and revolutionize cancer care worldwide!